Dextroamphetamine

Category
stimulant
Routes
Oral (PO)
Half-Life (t½)
PO: 10h
Formula
C9H13N
Molecular Weight
135.21 g/mol
PubChem CID
5826
Aliases
Dexedrine, D-amphetamine

Pharmacological Mechanism

Releases dopamine + norepinephrine via TAAR1 activation and reversal of DAT/NET vesicular transporters. Pure d-isomer is more CNS-selective (vs racemic MAS); narrower peripheral sympathetic profile than l-amphetamine.

Half-Life & Elimination Curve (PO: 10h)

100%50%25%12.5%0%0h0×t½10h1×t½20h2×t½30h3×t½40h4×t½50h5×t½0×t½ (0h): 100% remaining (~60.1 µg/L)1×t½ (10h): 50% remaining (~30 µg/L)2×t½ (20h): 25% remaining (~15 µg/L)3×t½ (30h): 12.5% remaining (~7.51 µg/L)4×t½ (40h): 6.3% remaining (~3.76 µg/L)5×t½ (50h): 3.1% remaining (~1.88 µg/L)
Plasma (PO)t½ Decay (10h)
  • 0×t½0h100% (60.1 µg/L)
  • 1×t½10h50% (30 µg/L)
  • 2×t½20h25% (15 µg/L)
  • 3×t½30h12.5% (7.51 µg/L)
  • 4×t½40h6.3% (3.76 µg/L)
  • 5×t½50h3.1% (1.88 µg/L)
Elimination t½10h (PO)
Rate Constant (ke)0.0693 h⁻¹
Time to Peak (Tmax)2.52h
Est. Peak (Cmax)60.1 µg/L
Clearance (CL)14.6 L/h
97% Washout (5×t½)50h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References